KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Varonis Systems (VRNS) Accumulated Expenses (2016 - 2025)

Varonis Systems (VRNS) has 13 years of Accumulated Expenses data on record, last reported at $225.4 million in Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 36.67% year-over-year to $225.4 million; the TTM value through Dec 2025 reached $225.4 million, up 36.67%, while the annual FY2025 figure was $225.4 million, 36.67% up from the prior year.
  • Accumulated Expenses reached $225.4 million in Q4 2025 per VRNS's latest filing, up from $193.1 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $225.4 million in Q4 2025 and bottomed at $102.2 million in Q4 2021.
  • Average Accumulated Expenses over 5 years is $159.1 million, with a median of $160.9 million recorded in 2024.
  • Peak YoY movement for Accumulated Expenses: grew 8.53% in 2023, then soared 36.67% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $102.2 million in 2021, then grew by 12.72% to $115.2 million in 2022, then rose by 8.53% to $125.1 million in 2023, then skyrocketed by 31.88% to $164.9 million in 2024, then soared by 36.67% to $225.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $225.4 million in Q4 2025, $193.1 million in Q3 2025, and $190.3 million in Q2 2025.